Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Valeant Pharmaceuticals Agrees to Acquire Inova

Nov. 20 (Bloomberg) -- Valeant Pharmaceuticals International Inc. said it has signed an agreement to acquire iNova.

Valeant will pay iNova shareholders A$625 million upfront and up to an additional A$75 million based on success of pipeline activities, product registrations and overall revenue. Link to Statement:{NSN LUZTTJ3T6SQO <GO>}

Link to Company News:{VRX CN <Equity> CN <GO>}

To contact the editor responsible for this story: Mike Millard at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.